ClearSign Technologies Corp (CLIR): Nasdaq/NYSE listing notice — ClearSign Technologies receives Nasdaq extension to Oct 30, 2023 to regain $1 bid price compliance

ClearSign Technologies Corp

Company previously disclosed bid price non-compliance on Nov 1, 2022; extension granted until Oct 30, 2023.
Nasdaq requires minimum bid price of $1.00 per share; company must regain compliance by Oct 30, 2023.
Company intends to cure deficiency via reverse stock split if necessary.
Trading on Nasdaq Capital Market continues under symbol 'CLIR' during extension period.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ClearSign Technologies Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 2, 2023, the Company received a second letter from Nasdaq granting the Company an additional 180 calendar days, or until October 30, 2023, to regain compliance with the Minimum Bid Price Requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Notice”). Nasdaq further stated in the Notice that its determination to grant an extension was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the e

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ClearSign Technologies Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-055099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.